Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q2 2019

Top Holdings401 positions

Checking export access…
Activity:

Facebook Inc

72.8M$14.1B4.5%$131.74+45.11%
3 qtrssince 2018-Q4
Increased
59

Microsoft Corp

94.3M$12.6B4.0%$94.43+32.94%
3 qtrssince 2018-Q4
Decreased
0

Netflix Inc

28.4M$10.4B3.3%$27.67+32.75%
3 qtrssince 2018-Q4
Increased
62

Abbott Laboratories

116.8M$9.8B3.1%$62.94+17.08%
3 qtrssince 2018-Q4
Increased
59

AbbVie Inc

110.1M$8B2.5%$66.47-19.09%
3 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

27.1M$7.8B2.5%$21.51+12.33%
3 qtrssince 2018-Q4
Increased
65

Amazon.com Inc

4.1M$7.8B2.5%$75.10+26.08%
3 qtrssince 2018-Q4
Decreased
0

Gilead Sciences Inc

81.7M$5.5B1.8%$47.29+9.24%
3 qtrssince 2018-Q4
Increased
53

Amgen Inc

29.6M$5.4B1.7%$153.91-3.78%
3 qtrssince 2018-Q4
Decreased
0

UnitedHealth Group Inc

22.1M$5.4B1.7%$217.32-1.01%
3 qtrssince 2018-Q4
Increased
61
BABABABA
ADR

Alibaba Group Holding Ltd

30.3M$5.1B1.6%$143.24+11.33%
3 qtrssince 2018-Q4
Increased
55

Exxon Mobil Corp

61.2M$4.7B1.5%$50.00+12.46%
3 qtrssince 2018-Q4
Decreased
0

Mastercard Inc

17.6M$4.7B1.5%$181.57+39.84%
3 qtrssince 2018-Q4
Increased
51

General Dynamics Corp

24.6M$4.5B1.4%$133.40+15.55%
3 qtrssince 2018-Q4
Increased
54

EOG Resources Inc

47.7M$4.4B1.4%$64.33+6.92%
3 qtrssince 2018-Q4
Increased
51

Intel Corp

87.7M$4.2B1.3%$40.43+3.17%
3 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

3.6M$3.9B1.2%$51.76+3.62%
3 qtrssince 2018-Q4
Decreased
0

Thermo Fisher Scientific Inc

12.9M$3.8B1.2%$219.16+31.41%
3 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

3.3M$3.6B1.1%$51.29+4.37%
3 qtrssince 2018-Q4
Decreased
0

CSX Corp

45.3M$3.5B1.1%$19.00+23.24%
3 qtrssince 2018-Q4
Increased
53
$315B
AUM
401
Positions
Q2 2019
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+10%Q1'19$315.5B-0%Q2'19$315B
Activity profile
$ moved · Q2'19
New8%Increased40%Decreased47%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 quarters
<1Q8%1-4Q92%1-2Y0%2Y+0%

Capital Research Global Investors manages $315B across 401 positions as of Q2 2019. Top holdings: META (4.5%), MSFT (4.0%), NFLX (3.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q2 2019 Summary

Active quarter - 31 new positions, 45 exits, 207 increased. Top move: AVGO (INCREASED, conviction 65). Portfolio: $315.0B across 401 positions.

Top holdings by portfolio weight

Total AUM$315B
META4.46%
MSFT4.01%
NFLX3.31%
ABT3.12%
ABBV2.54%
AVGO2.48%
AMZN2.47%
GILD1.75%
AMGN1.73%
UNH1.71%
Other1.63%

Portfolio allocation by GICS sector

Sectors11
Healthcare18.79%
Technology15.24%
Consumer Cyclical12.46%
Communication Services11.59%
Financial Services7.75%
Industrials7.62%
Consumer Defensive6.70%
Energy6.19%
Unknown6.13%
Basic Materials3.70%
Other3.84%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used